The Gamble Behind a Takeover of Kenvue, Maker of Tylenol
04.11.25 14:17 Uhr
Werbung
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.Weiter zum vollständigen Artikel bei New York Times
Quelle: New York Times